ロード中...
Efficacy of 12-weeks velpatasvir plus sofosbuvir-based regimen in HCV-naive subjects with mild fibrosis: a meta-analysis
BACKGROUND AND AIMS: In literature systematic data on treatment with the fixed-dose combination of sofosbuvir and velpatasvir for 12 weeks in anti-HCV/HCV RNA positive subjects with mild fibrosis and naïve to previous Interferon free regimen are scanty. A meta-analysis has been performed to evaluate...
保存先:
| 出版年: | Acta Biomed |
|---|---|
| 主要な著者: | , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Mattioli 1885
2019
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6776220/ https://ncbi.nlm.nih.gov/pubmed/31124995 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.23750/abm.v90i2.8374 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|